share_log

Nasdaq Skydives amid Continued US Stock Volatility; HSI to Test 19,200 in Near-term

Nasdaq Skydives amid Continued US Stock Volatility; HSI to Test 19,200 in Near-term

納斯達克在美國股市持續震盪中跳水;恆生指數近期將測試19,200點
阿斯達克財經 ·  2022/05/11 23:00

U.S. equities remained on a bumpy ride overnight (11th), commented Stanley Chik, a research head at Bright Smart. Driven by the rally of technology shares, the three major U.S. indices advanced earlier in the session. The upward momentum, however, was curbed by the hawkish comments from Federal Reserve officials later in the day, leading the three indices to close down. Nasdaq, in particular, eroded 373 pts or 3.2%, to close at 11,364.

As for the Hong Kong market, the HSI once recuperated to above 20,000, on the back of the satisfactory performance from A-shares and rebound of new economy stocks. The index closed at 19,824, up 190 pts, on a turnover of $126.1 billion. Among the constituent stocks, autos were particularly brisk, with GEELY AUTO (00175.HK) and BYD COMPANY (01211.HK) climbing 6.8% and 8.5%, respectively.

Following the sharp declines posted by U.S. stocks, the HSI will likely open down today. Should the A-shares manage to maintain the rising momentum, the H-shares should be supported by a certain extent. However, Chik remarked that the overall sentiment remains uncertain, with the investment sentiment vexed by the looming concerns about inflation and potential recession. The HSI, therefore, may test lower at 19,200, Chik anticipated.

(The author is the licensee of SFC, who does not hold the related shares)

Bright Smart的研究主管Stanley Chik評論説,美國股市一夜之間仍然坎坷(第11位)。在科技股反彈的推動下,美國三大股指在盤中早些時候上漲。然而,美聯儲官員當天晚些時候發表的鷹派言論抑制了上漲勢頭,導致三大股指收盤下跌。尤其是納斯達克,下跌了373點,跌幅3.2%,收於11,364點。

至於香港市場,在A股表現理想和新經濟股反彈的支持下,恆指一度回升至2萬點以上。該指數收於19824點,上漲190點,成交額為1261億美元。在成分股中,汽車類股尤為活躍,吉利汽車(00175.HK)和比亞迪股份(01211.HK)分別攀升6.8%和8.5%。

隨着美國股市的大幅下跌,恆生指數今天可能會開盤下跌。如果A股能夠保持上漲勢頭,H股應該會得到一定的支撐。然而,Chik表示,整體情緒仍不確定,對通脹和潛在衰退的擔憂迫在眉睫,令投資情緒感到不安。因此,Chik預計恆生指數可能會測試較低的19,200點。

(作者為證監會持牌人,未持有相關股份)

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論